Explore

Nanomedicine 2020

PHARMACEUTICAL NANOTECHNOLOGY & NANOMEDICINE CONGRESS 2020

Chicago, United States
22 - 23 June 2020
The conference ended on 23 June 2020

Important Dates

Abstract Submission Deadline
31st January 2020
Early Bird Deadline
31st January 2020
Abstract Acceptance Notification
3rd February 2020
Final Abstract / Full Paper Deadline
1st May 2020

About Nanomedicine 2020

LexisConferences is pleased to welcome all the interested participants to Nanomedicine 2020 during June 22-23, 2020 at Chicago, USA which focusses on the major topics like Advanced Nanomedicine & Nanotechnology.

Topics

Nanobiotechnology, Nanoparticles, Nanoscience, Nano-medicine & drug delivery, Nanomedicine, Nanofabrication nanotoxicity nanomedicine nanoengineering nanobiotechnology materials science molecular engineering graphenes nanophotonics cosmetics defense and securityrecent innovations and others

Call for Papers

LexisConferences is pleased to welcome all the interested participants to Nanomedicine 2020 during JUNE 22-23, 2020 at Chicago, USA which focusses on the major topics like Nanosceince & Nanoengineering, Nano medicine & Nanotechnology, Pharmaceutical Technology, Emergency of Nanomedicine, Nanotechnology in Tissue Engineering and many more. Nanomedicine Congress 2019 welcomes all the Researchers and Ph.D Scholars from academia, clinicians, R&D Researchers, CEOs, CROs, CMOs, Director, President from Pharmaceutical Companies, Manufacturers, Distributors, Business Entrepreneurs, Health professionals & Pharmacist, Quality control specialist from research labs, industries and healthcare sectors to be a part of the conference to share their knowledge on all parts of this rapidly expanded field and then, by providing a showcase of the research in this field and uncovering the innovative ideas.

Last date for Early bird is January 31, 2020

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.